CU01-1001

· Curacle Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CU01-1001, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria [Phase 2]

See pricing